Pharmaceuticals

One of the primary drivers of the Montelukast Sodium Market is the increasing prevalence of asthma boosting market demand

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Montelukast Sodium Market At The End Of The 2026–2030 Forecast Period?

The montelukast sodium market has experienced robust expansion in recent years. Its valuation is projected to increase from $4.2 billion in 2025 to $4.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to its historical growth include the extensive clinical application of montelukast in managing asthma, the rising incidence of allergic respiratory conditions, a well-established safety record for prolonged treatment, broad acceptance by physicians for maintenance regimens, and the existence of affordable generic alternatives.

The montelukast sodium market is projected for substantial growth in the upcoming years, with an anticipated expansion to $6.33 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period is attributable to the increasing global burden of asthma and allergic rhinitis, rising pediatric asthma diagnosis rates, enhanced awareness of non-steroidal asthma therapies, broader access to respiratory medicines in emerging markets, and a sustained demand for oral maintenance drugs. Major trends influencing this period include a growing demand for leukotriene receptor antagonists in asthma management, an expanding application of montelukast in allergic rhinitis treatment, the proliferation of generic montelukast sodium formulations, a preference for oral solid dosage forms in chronic respiratory therapy, and an increase in prescriptions for both pediatric and adult asthma patients.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What Drivers Are Shaping The Future Growth Of The Montelukast Sodium Market?

The expanding occurrence of asthma is anticipated to stimulate the expansion of the montelukast sodium market in the future. Asthma, a persistent respiratory ailment, is characterized by airway inflammation and narrowing, leading to recurrent episodes of wheezing, difficulty breathing, chest tightness, and coughing. The rise in asthma prevalence stems from factors such as environmental contamination, exposure to allergens, genetic susceptibility, urban development, evolving lifestyles, and respiratory illnesses. Montelukast sodium serves as a leukotriene receptor antagonist in asthma treatment, aiding in the prevention and control of symptoms by inhibiting leukotriene activity, which plays a role in airway inflammation and constriction. For example, data from October 2024, provided by the National Asthma Council, an Australia-based non-profit organization, indicates that in 2023, Australia registered a total of 474 deaths linked to asthma, consisting of 325 females and 149 males. This number is nearly identical to the 473 asthma-related deaths documented in 2022, underscoring a steady pattern in asthma fatalities across these two years. Consequently, the growing incidence of asthma is fueling the expansion of the montelukast sodium market.

What Segment Types Make Up The Montelukast Sodium Market?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Which Market Trends Are Creating New Opportunities In The Montelukast Sodium Market?

Leading firms within the montelukast sodium market are prioritizing the creation of novel solutions, including combination therapies, to offer more extensive relief for allergies and asthma and enhance patient compliance. These combination therapies involve administering two or more medications concurrently within one treatment plan, aiming to address several disease mechanisms for improved effectiveness. As an illustration, during October 2025, Cadila Pharmaceuticals Ltd., a pharmaceutical company based in India, introduced Dlorfast-M tablets. This product is a fixed-dose combination therapy comprising desloratadine (5 mg) and montelukast (10 mg), intended for the treatment of allergic rhinitis and urticaria. This formulation offers comprehensive symptom management by concurrently addressing both the histamine and leukotriene pathways, delivered through a convenient once-daily oral dose. The goal of this inventive formulation is to enhance patient compliance and provide sustained relief while maintaining good tolerability.

Who Are The Key Players Driving Competition In The Montelukast Sodium Market?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Read the full montelukast sodium market report here:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Geographic Regions Are Influencing Demand In The Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Montelukast Sodium Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

Browse Through More Reports Similar to the Global Montelukast Sodium Market 2026, By The Business Research Company

Montelukast Sodium Market Report 2026

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Sodium Reduction Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

Sodium Benzoate Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-benzoate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795